355 related articles for article (PubMed ID: 6930928)
21. Regulation of plasma lecithin:cholesterol acyltransferase in man. III. Role of high density lipoprotein cholesteryl esters in the activating effect of a high-fat test meal.
Rose HG; Juliano J
J Lipid Res; 1979 Mar; 20(3):399-407. PubMed ID: 221605
[TBL] [Abstract][Full Text] [Related]
22. Evidence for the presence in human plasma of lecithin: cholesterol acyltransferase activity (beta-LCAT) specifically esterifying free cholesterol of combined pre-beta- and beta-lipoproteins. Studies of fish eye disease patients and control subjects.
Carlson LA; Holmquist L
Acta Med Scand; 1985; 218(2):197-205. PubMed ID: 4061123
[TBL] [Abstract][Full Text] [Related]
23. Transport of lipids in blood plasma.
Norum KR
Bibl Nutr Dieta; 1977; (25):70-7. PubMed ID: 199156
[No Abstract] [Full Text] [Related]
24. Increases in the particle size of high-density lipoproteins induced by purified lecithin: cholesterol acyltransferase: effect of low-density lipoproteins.
Rajaram OV; Barter PJ
Biochim Biophys Acta; 1986 Jul; 877(3):406-14. PubMed ID: 3730408
[TBL] [Abstract][Full Text] [Related]
25. Familial lecithin:cholesterol acyltransferase deficiency: further resolution of lipoprotein particle heterogeneity in the low density interval.
Guérin M; Dolphin PJ; Chapman MJ
Atherosclerosis; 1993 Dec; 104(1-2):195-212. PubMed ID: 8141844
[TBL] [Abstract][Full Text] [Related]
26. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein AIMilano. Partial lecithin:cholesterol acyltransferase deficiency due to low levels of a functional enzyme.
Franceschini G; Baio M; Calabresi L; Sirtori CR; Cheung MC
Biochim Biophys Acta; 1990 Mar; 1043(1):1-6. PubMed ID: 2106917
[TBL] [Abstract][Full Text] [Related]
28. Lecithin:cholesterol acyltransferase in familial HDL deficiency (Tangier disease).
Pritchard PH; McLeod R; Frohlich J; Park MC; Kudchodkar BJ; Lacko AG
Biochim Biophys Acta; 1988 Feb; 958(2):227-34. PubMed ID: 3122840
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithin-cholesterol acyltransferase.
Itabe H; Hosoya R; Karasawa K; Jimi S; Saku K; Takebayashi S; Imanaka T; Takano T
J Biochem; 1999 Jul; 126(1):153-61. PubMed ID: 10393333
[TBL] [Abstract][Full Text] [Related]
30. Study of the components of reverse cholesterol transport in lecithin:cholesterol acyltransferase deficiency.
Park MS; Kudchodkar BJ; Frohlich J; Pritchard H; Lacko AG
Arch Biochem Biophys; 1987 Nov; 258(2):545-54. PubMed ID: 3674887
[TBL] [Abstract][Full Text] [Related]
31. Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver.
Hamilton RL; Williams MC; Fielding CJ; Havel RJ
J Clin Invest; 1976 Sep; 58(3):667-80. PubMed ID: 182724
[TBL] [Abstract][Full Text] [Related]
32. Lipoprotein products of lecithin: cholesterol acyltransferase and cholesteryl ester transfer.
Rose HG; Ellerbe P
Biochim Biophys Acta; 1982 Sep; 712(3):547-56. PubMed ID: 7126623
[TBL] [Abstract][Full Text] [Related]
33. Normalization of high density lipoprotein in fish eye disease plasma by purified normal human lecithin: cholesterol acyltransferase.
Holmquist L; Carlson LA
Lipids; 1988 Mar; 23(3):225-9. PubMed ID: 3374277
[TBL] [Abstract][Full Text] [Related]
34. The in vitro formation of HDL2 during the action of LCAT: the role of triglyceride-rich lipoproteins.
Dieplinger H; Zechner R; Kostner GM
J Lipid Res; 1985 Mar; 26(3):273-82. PubMed ID: 3989387
[TBL] [Abstract][Full Text] [Related]
35. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of normal high density lipoproteins on lecithin:cholesterol acyltransferase activity in fish eye disease plasma.
Holmquist L; Carlson LA
Acta Med Scand; 1987; 222(1):15-21. PubMed ID: 3630774
[TBL] [Abstract][Full Text] [Related]
37. Factors affecting the conversion of high-density lipoproteins: experiments with pig and human plasma.
Knipping G; Zechner R; Kostner GM; Holasek A
Biochim Biophys Acta; 1985 Jul; 835(2):244-52. PubMed ID: 4005282
[TBL] [Abstract][Full Text] [Related]
38. Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities.
Kunitake ST; Mendel CM; Hennessy LK
J Lipid Res; 1992 Dec; 33(12):1807-16. PubMed ID: 1479290
[TBL] [Abstract][Full Text] [Related]
39. Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics.
Prager R; Schernthaner G; Kostner GM; Mühlhauser I; Zechner R; Dorda W
Atherosclerosis; 1982 Jun; 43(2-3):321-7. PubMed ID: 6810904
[TBL] [Abstract][Full Text] [Related]
40. Role of LCAT in HDL remodeling: investigation of LCAT deficiency states.
Asztalos BF; Schaefer EJ; Horvath KV; Yamashita S; Miller M; Franceschini G; Calabresi L
J Lipid Res; 2007 Mar; 48(3):592-9. PubMed ID: 17183024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
